CVE-2023-20229 Details
Description
A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks and overwrite arbitrary files on an affected system. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by executing a directory traversal attack on an affected host. A successful exploit could allow an attacker to use a cryptographic key to overwrite arbitrary files with SYSTEM-level privileges, resulting in a denial of service (DoS) condition or data loss on the affected system.
Metrics
CVSS 4.0 Severity and Vector Strings:
No CVSS 4.0 data is available for this CVE.
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Nov 21, 2024References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-duo-dha-filewrite-xPMBMZAK | CVE | PatchVendor Advisory |
| https://sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-duo-dha-filewrite-xPMBMZAK | [email protected] | PatchVendor Advisory |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-22 | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') | [email protected] |
| CWE-22 | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| cisco duo device health application | >= 5.0.0, < 5.2.0 |
CPE
Remediation
| |
Change History
6 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Nov 21, 2024 | CVE Modified | CVE |
| May 14, 2024 | CVE Modified | [email protected] |
| Jan 25, 2024 | CVE Modified | [email protected] |
| Aug 25, 2023 | Initial Analysis | [email protected] |